Cardinal Health, Inc.
HealthcareNYSE:CAH · New York Stock Exchange
+$2.69 today
Vol 2.20M · Avg 2.05M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-56.1%
avg -4.4%
ROIC
11.4%
avg 3.1%
ROA
2.9%
avg 1.0%
Analysis
ROIC is currently the strongest return metric at 11.4% versus its period average of 3.1%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Jason Hollar | Chief Executive Officer & Director | $5.54M | — | 53 | $200,000.00 | 0.09% |
Aaron E. Alt | Chief Financial Officer | $2.23M | — | 54 | $26,408.00 | 0.01% |
Deborah L. Weitzman | Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment | $1.74M | — | 61 | $52,877.00 | 0.02% |
Jessica L. Mayer | Chief Legal & Compliance Officer | $1.72M | — | 57 | $34,427.00 | 0.01% |
Stephen Mason | Chief Executive Officer of GMPD segment | $1.39M | — | 55 | $25,490.00 | 0.01% |
Patricia English | Senior Vice President | $451,344.00 | — | 46 | $28,645.00 | 0.01% |
Craig Cowman | President of Biopharma Solutions & Strategic Sourcing | — | — | — | $126,301.00 | 0.05% |
Matt Sims | Vice President of Investor Relations | — | — | — | — | — |
Mary C. Scherer | Senior Vice President & Chief Accounting Officer | — | — | — | $3,495.00 | <0.01% |
Valerie Christine Pitteroff | Chief Human Resources Officer | — | — | — | $8,022.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
23
$52.95M
Net Sentiment
$52.95M
Net selling
Most Active
Hollar Jason M.
5 transactions
1–10 of 23
Analysis
Insiders reported 0 buys worth $0.00 and 23 sells worth $52.95M over the last 12 months. That adds up to net selling of $52.95M. Hollar Jason M. was the most active insider with 5 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +5.8% | +11.3% (15yr)1 analysts |
| Revenue | N/A | N/A | -1.6% | +8.3% (15yr)6 analysts |
| Net Income | N/A | N/A | +4.4% | +8.9% (15yr)6 analysts |
| EBIT | N/A | N/A | +6.4% | +8.6% (15yr)6 analysts |
Analysis
Recent growth has been strongest in EBIT at +6.4% over three years. Forward estimates point to EPS at +11.3% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
argenx SE
NASDAQ:ARGX
$55.29B
Cencora, Inc.
NYSE:COR
$54.80B
Becton, Dickinson and Company
NYSE:BDX
$52.98B
Edwards Lifesciences Corporation
NYSE:EW
$49.01B
Haleon plc
NYSE:HLN
$40.31B
Agilent Technologies, Inc.
NYSE:A
$36.67B
IQVIA Holdings Inc.
NYSE:IQV
$30.29B
ResMed Inc.
NYSE:RMD
$28.25B
Veeva Systems Inc.
NYSE:VEEV
$25.92B
Bruker Corporation
NASDAQ:BRKR
$8.26B
Who manages CAH?
Cardinal Health, Inc. (CAH) lists 10 active executives. The top listed executive is Aaron E. Alt, Chief Financial Officer.
Are CAH insiders buying or selling?
Recent insider activity shows net selling of $148.81M.
Explore More
Continue the stock analysis
Jump to another research area for this company.